Haemophilia and Thrombosis Centre, University Hospital of Wales, Cardiff, UK.
Br J Haematol. 2013 Sep;162(6):748-57. doi: 10.1111/bjh.12474. Epub 2013 Jul 15.
Central venous catheters are commonly used in haematology departments for the administration of chemotherapy, blood products and parenteral nutrition in patients with haematological malignancy. Thrombosis is a recognized complication of such devices especially in oncology patients. Catheter-related thrombi (CRT) may lead to pulmonary embolism and infection, as well as catheter failure and potential delays in treatment. The vast majority of CRT are asymptomatic, thus a high index of suspicion is required in making the diagnosis. Doppler ultrasound or venography may be employed to identify CRT. Once confirmed, the initiation of treatment is a balance between the risks of anticoagulation against potential complications of CRT. A number of risk factors for CRT are discussed along with an overview of catheter types, their appropriate choice and intravascular positioning.
中心静脉导管在血液科常用于血液病患者化疗、血制品和肠外营养的输注。血栓形成是此类装置的公认并发症,尤其是在肿瘤患者中。导管相关性血栓(CRT)可导致肺栓塞和感染,以及导管故障和潜在的治疗延误。绝大多数 CRT 是无症状的,因此需要高度怀疑以做出诊断。多普勒超声或静脉造影可用于识别 CRT。一旦确诊,治疗的启动是在抗凝的风险与 CRT 的潜在并发症之间进行平衡。本文讨论了 CRT 的一些危险因素,并概述了导管类型、适当选择和血管内定位。